METHOD FOR ESTIMATING CLINICAL COURSE SEVERITY OF STREPTOCOCCAL IMPETIGO CASES Russian patent published in 2005 - IPC

FIELD: medicine.

SUBSTANCE: method involves examining testee blood serum samples on tablets covered with sorbable F(ab)₂-fragments of idiotypic and anti-idiotypic antibodies to tumor necrosis factor TNFα (TNFα itself is applicable instead of F(ab)₂-fragments of anti-idiotypic antibodies to TNFα). Concentration of idiotypic and anti-idiotypic antibodies to TNFα is determined in testing. The value under study not violating the limit of 145% relative to reference blood serum response, streptococcal impetigo clinical course is estimated as mild one. One or both determined values being higher than 145% but not exceeding 175%, streptococcal impetigo clinical course is estimated as moderate one. One or both determined values exceeding 175%, streptococcal impetigo clinical course is estimated as heavy one.

EFFECT: high accuracy and objectivity of estimates.